Safety Alerts Saves Lives
Safety Alerts  
Home Privacy About Us Contact Us Change Preferences
" "
Safety Alerts
August 17, 1999

Bausch & Lomb Pharmaceuticals Recalls Erythromycin Ophthalmic Ointment

Tampa, FL (SafetyAlerts) - The Food and Drug Administration (FDA) today reported that Bausch & Lomb Pharmaceuticals is recalling Erythromycin Ophthalmic Ointment because of a product mix-up.  Correctly labeled Muro 128Æ Ointment tube (sodium chloride 5%) was found in a carton of erythromycin product.

Erythromycin Ophthalmic Ointment, USP, 0.5%, Rx, in 3.5 g tubes.

Recall #D-299-9.

Lot #065151 EXP 5/00.

Bausch & Lomb Pharmaceuticals, Inc., Tampa, Florida.

Manufacturer, by letter mailed on July 22, 1999, followed by letter and telephone. Firm-initiated recall ongoing.


49,968 units were distributed.


The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.